Cash Flow Kissei Pharmaceutical Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
15,610.00
14,449.00
13,680.00
16,507.00
7,476.00
4,630.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-668.00
-9,288.00
-5,473.00
94.00
-7,680.00
9,304.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
6,521.00
-1,677.00
-6,679.00
1,533.00
-2,542.00
13,934.00
Cash Flow from Investing Activities
4,952.00
8,690.00
6,001.00
10,776.00
-9,329.00
490.00
Cash Flow from Financing Activities
-9,325.00
-10,006.00
-3,420.00
-2,756.00
-4,000.00
-4,419.00
Net Cash Inflow / Outflow
2,175.00
-2,996.00
-4,119.00
9,557.00
-15,871.00
10,005.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
27.00
-3.00
-21.00
4.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Kissei Pharmaceutical Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
15610
-305
15,915.00
5218.03%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-668
-605
-63.00
-10.41%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
6521
2645
3,876.00
146.54%
Cash Flow from Investing Activities
4952
-7990
12,942.00
161.98%
Cash Flow from Financing Activities
-9325
-485
-8,840.00
-1822.68%
Net Cash Inflow / Outflow
2175
-5051
7,226.00
143.06%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
27
779
-752.00
-96.53%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 488.85% vs 74.89% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
6,521.00
-1,677.00
488.85%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
